Son, Nayeong
Choi, Eunmi
Chung, Soo Youn
Han, Soon Young
Kim, Bonggi
Article History
Received: 4 March 2021
Accepted: 31 January 2022
First Online: 13 February 2022
Declarations
:
: Ethics approval for this study was obtained from the institutional review board of Korea Institute of Drug Safety and Risk Management, which waived informed consent (IRB approval number 2019-4). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.